Provided by Tiger Fintech (Singapore) Pte. Ltd.

Adt Inc.

7.98
-0.1000-1.24%
Volume:26.39M
Turnover:210.35M
Market Cap:6.84B
PE:14.98
High:8.13
Open:8.07
Low:7.80
Close:8.08
Loading ...

3 Reasons to Sell ADT and 1 Stock to Buy Instead

StockStory
·
06 Jan

Tap These 5 Bargain Stocks With Impressive EV-to-EBITDA Ratio

Zacks
·
20 Dec 2024

BRIEF-Adt Inc - Entered Into Agreement With Non-Affiliate Individual To Repurchase 15 Million Shares For $104.2 Million

Reuters
·
18 Dec 2024

ADT Inc - Entered Into Agreement With Non-Affiliate Individual to Repurchase 15 Mln Shares for $104.2 Mln

THOMSON REUTERS
·
18 Dec 2024

Are Investors Undervaluing ADT (ADT) Right Now?

Zacks
·
13 Dec 2024

ADT Inc. price target raised to $9 from $8.50 at Morgan Stanley

TIPRANKS
·
12 Dec 2024

Morgan Stanley Reaffirms Their Hold Rating on Adt (ADT)

TIPRANKS
·
12 Dec 2024

BUZZ-Seaport Research Partners downgrades SiriusXM after revenue forecast miss

Reuters
·
11 Dec 2024

Intra-Cellular Therapies Presents Data from the CAPLYTA Adjunctive MDD Phase 3 Program at the American College of Neuropsychopharmacology Annual Meeting

GlobeNewswire
·
11 Dec 2024

Candel Therapeutics Announces CAN-2409 Achieved Primary Endpoint in Phase 3 Prostate Cancer Trial, Showing Significantly Improved Disease-Free Survival

GlobeNewswire
·
11 Dec 2024

BUZZ-SiriusXM slides after rev guidance miss, exec changes

Reuters
·
11 Dec 2024

SiriusXM Appoints Wayne Thorsen as COO

MT Newswires Live
·
10 Dec 2024

SiriusXM Hires ADT Executive for New COO Role

Dow Jones
·
10 Dec 2024

Sirius XM names Wayne Thorsen as COO

TIPRANKS
·
10 Dec 2024

ADT Inc. Announces Leadership Changes Amid Strategic Shift

TIPRANKS
·
10 Dec 2024

NCCN Prostate Cancer Guidelines Reinforce Status of Myriad Genetics' Prolaris® Test as an 'Advanced Tool' Recommended for Prognostic Assessment

GlobeNewswire
·
09 Dec 2024

4 Stocks to Gain From the Thriving Security and Safety Industry

Zacks
·
04 Dec 2024

The Zacks Analyst Blog Highlights Roche, Poseida Therapeutics, Merck, AstraZeneca and Novartis

Zacks
·
02 Dec 2024

Pharma Stock Roundup: RHHBY to Buy PSTX, MRK, AZN See Pipeline Success

Zacks
·
30 Nov 2024

AstraZeneca's Combination Therapy Meets Goal in Prostate Cancer Study

Zacks
·
27 Nov 2024